Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Payables (2021 - 2025)

Core Scientific's Payables history spans 5 years, with the latest figure at $212.2 million for Q3 2025.

  • For Q3 2025, Payables rose 767.99% year-over-year to $212.2 million; the TTM value through Sep 2025 reached $212.2 million, up 767.99%, while the annual FY2024 figure was $35.6 million, 87.26% down from the prior year.
  • Payables for Q3 2025 was $212.2 million at Core Scientific, down from $215.1 million in the prior quarter.
  • Across five years, Payables topped out at $1.0 billion in Q3 2022 and bottomed at $86179.0 in Q1 2021.
  • The 5-year median for Payables is $86.0 million (2023), against an average of $145.9 million.
  • The largest annual shift saw Payables skyrocketed 145872.92% in 2022 before it plummeted 87.26% in 2024.
  • A 5-year view of Payables shows it stood at $87.6 million in 2021, then increased by 2.59% to $89.9 million in 2022, then soared by 210.52% to $279.1 million in 2023, then tumbled by 87.26% to $35.6 million in 2024, then skyrocketed by 496.76% to $212.2 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Payables are $212.2 million (Q3 2025), $215.1 million (Q2 2025), and $22.5 million (Q1 2025).